Social Media Influencers Driving Unofficial Trade for Unapproved Slimming Drug

An underground market for unapproved slimming drugs is being driven by TikTok fitness influencers and sellers on messaging platforms, based on recent findings.

Experimental Treatment Acquiring Traction Via Social Media

Retatrutide, which is still in clinical trials, is being advertised by social media influencers for its alleged fat-burning properties. Viewers are urged to message these accounts privately for source information, while also obtaining promotional offers.

Thriving Trade on Messaging Platforms

Additionally, a robust market exists on Telegram, where communities with thousands of members share comparison images, injection guides and assertions of rapid British shipping. Sellers market the drug there before redirecting buyers to other platforms for transactions.

Understanding The Experimental Drug

This medication is an investigational injectable developed by US drugmaker Eli Lilly. The drug targets three intestinal hormones – glucagon-like peptide-1, GIP and glucagon. Preliminary studies indicate it could help patients reduce up to a quarter of their body weight. Referred to as the “triple G”, the drug is being promoted digitally as the next Ozempic.

Medical Professionals Voice Concerns

Nevertheless, physicians and chemists have cautions that the distribution of what remains an unlicensed drug in the UK is worrisome and could lead to individuals administering substances of unknown origin.

Several professionals said the demand for the experimental drug could be linked to the increasing cost of approved weight loss products such as Mounjaro.

Regulatory Status and Enforcement

Marketing retatrutide on social media or Telegram is prohibited in the UK, as it is an unapproved medication that cannot be promoted or supplied for personal consumption under the Human Medicines Regulations 2012.

Several content creators attempt to circumvent the rules by calling to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled drug, but advertising and supply can still violate pharmaceutical, marketing, and customer regulations, potentially leading to fines, prosecution or prison.

Service Response and Content Removal

According to the social media company, the service has taken down problematic content and prohibited associated hashtags and query recommendations. The organization said it was committed to maintaining the platform secure and investing in enhancing enforcement strategies.

Digital Trading Activities

Research also discovered communities with up to nine thousand members marketing the experimental drug using the platform's built-in search feature, which operates like a online catalog. Typing “retatrutide” instantly brings up channels with thousands of members, populated with photos of weight loss, glowing testimonials and step-by-step instructions for preparing or injecting at residence.

After moments of entering one community, a seller posted WhatsApp details, where most purchases take place. The vendor provided an guidebook and guaranteed shipping within two days. When questioned whether the product was genuine, one seller said: “You can’t be sure.” Another shared a image of a alleged laboratory certificate. Not one inquired about body mass, medical conditions or past usage.

Product Information and Costs

Inside these groups, posts display black plastic packages with Royal Mail stickers, claiming to include new batches. One communication stated: “It took eight of us to load them this morning.”

Customers can select between dry substance containers, mixed at home with purified liquid, or ready-to-use injectors usually sold at £160 for 20mg. When asked how long a injector should be used, vendors give contradictory responses varying between a few weeks to “depends on your body”.

Platform Oversight and Safety Measures

A spokesperson for the messaging service said it actively monitored dangerous material on its platform including content that encouraged the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.

Medical Expert Warnings

“Individuals are injecting substances they cannot confirm. Although the research behind this drug is valid, these digital versions may not contain what they advertise,” said a pharmacy expert, the director of pharmaceutical services at a pharmacy service.

A medical professional of an online medical service connected the surge in demand to recent price rises for authorized slimming medications such as Mounjaro. “With prices rising, patients are turning to online platforms. But fake treatments are extremely dangerous. You cannot know what’s inside or whether the environment they were made in was clean,” she explained.

Her team has already seen patients harmed by self-injection from unconfirmed suppliers. “We recognize the disappointment, but buying from messaging apps or communication platforms is gambling with your health,” said the doctor. “These materials could be impure or improperly measured.”

Manufacturer Statement

A representative from the pharmaceutical company stated the substance was in phase 3 clinical trials and had not been evaluated or approved by any government authority anywhere in the world. “Consequently at this time no one can market [it] for human use,” they said, noting that any item “misleadingly claiming itself as a Lilly investigational substance not yet authorized … may expose users to possibly significant medical dangers”.